Related Experiment Video

Updated: Jun 8, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Venous and arterial thrombosis: Two aspects of the same disease?

Paolo Prandoni1

  • 1Department of Cardiothoracic and Vascular Sciences, Thromboembolism Unit, University Hospital of Padua Padua, Italy.

Clinical Epidemiology
|September 25, 2010
PubMed

Insights

Evidence suggests a link between venous and arterial thrombosis, sharing risk factors and conditions. Future research is needed to understand this association and its clinical implications for thrombosis patients.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Thrombosis Research

Background:

  • Growing evidence indicates a connection between venous and arterial thrombosis.
  • Shared risk factors include age, obesity, diabetes mellitus, hypertension, hypertriglyceridemia, and metabolic syndrome.
  • Conditions like antiphospholipid antibody syndrome, hyperhomocysteinemia, malignancies, infections, and hormonal treatments can cause both types of thrombosis.

Purpose of the Study:

  • To explore the potential link between venous and arterial thrombosis.
  • To identify common risk factors and conditions associated with both vascular complications.
  • To hypothesize the underlying biological mechanisms driving the co-occurrence of these thrombotic events.

Main Methods:

  • Review of existing literature and epidemiological studies.
  • Analysis of shared risk factors and predisposing conditions.
  • Synthesis of recent findings on venous thromboembolism patients' risk for arterial complications.

Main Results:

  • Patients with venous thromboembolism demonstrate an elevated risk of arterial thrombotic events compared to controls.
  • Numerous shared risk factors and conditions contribute to the development of both venous and arterial thrombosis.
  • Biological stimuli activating coagulation and inflammatory pathways are hypothesized to link these conditions.

Conclusions:

  • Venous and arterial thrombosis may be simultaneously triggered by common biological stimuli.
  • Further investigation is crucial to elucidate the nature and extent of this association.
  • Understanding this link could have significant implications for clinical practice and patient management.

Keywords:
atherosclerosisdeep vein thrombosisischemic strokemyocardial infarctionpulmonary embolismvenous thromboembolism

More Related Videos

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...